Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. On November 22, 2022, the FDA approved CSL Behring’s Hemgenix (etranacogene dezaparvovec), the first gene therapy treatment for hemophilia B, with a staggering manufacturer price of $3.5

FDA 105

FDA 105

pharmaphorum

JANUARY 21, 2022

“Access to medicines remains one of the most challenging policy areas in every country we work with through the pan-European region,” said Natasha Muscat, Director of Country Health Policies and Systems at World Health Organization (WHO) Europe. WHO is OMI? And that’s exactly what the OMI is setting out to do. About the author.

Insurance 52

Insurance Vaccines 52

pharmaphorum

JUNE 8, 2021

That was the damning conclusion of the influential Institute for Clinical and Economic Review (ICER) in the US to yesterday’s approval of Aduhelm (aducanumab), the first new treatment for Alzheimer’s since 2003, which it says has “no evidentiary basis.” billion in 2027.

FDA 98

FDA Labelling 98

pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S. Professional reception of the findings.

Immunization 52

Immunization Hospitals Vaccines 52

PharmaShots

MARCH 9, 2023

Other Affiliations: Alison works as a visiting researcher at Imperial College's Institute of Biomedical Engineering. For her efforts to promote inclusion, equity, and diversity, she was given the President's AwardTM by the National Diversity Council in 2021. Present company and time period: Tivic Health (6 yrs.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

The Checkup by Singlecare

JANUARY 23, 2024

Benign skin growths Skin growths such as moles, skin tags, and seborrheic keratosis can appear as bumps on the head. An individual’s overall health condition, age, and the severity of the head bump can all influence how long a bump on the head will last. Bone spurs : Bone spurs don’t typically go away unless they’re surgically removed.

52

52

European Pharmaceutical Review

MAY 11, 2023

3 The one-time gene therapy received final draft guidance from the National Institute for Health and Care Excellence (NICE) on 16 March 2023. 1 This is assuming a $1M price tag for all gene therapies. Health Resources – pharmaceutical spending – OECD Data [Internet] [cited 2023Apr]. cited 2023May].

FDA 65

FDA 65